Indivumed joins Blood Profiling Atlas in Cancer (Blood PAC)
Indivumed GmbH, a global oncology research company with a unique global clinical network, bio repository and cancer data base will contribute research expertise and vital blood samples with associated clinical data to the Blood PAC, an initiative launched in response to Vice President Biden’s Cancer Moonshot initiative.
The Blood PAC, a public private partnership of various leading oncology companies and academic institutions will enable development of an open database for liquid biopsies to potentially accelerate the development of safe and effective blood profiling technologies, advancing the diagnosis and treatment of cancer.
